PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsKristalose
Kristalose
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
206 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hepatic encephalopathyD006501—K72.91487161851
Brain diseasesD001927—G93.40184101435
Liver cirrhosisD008103EFO_0001422K74.016571631
FibrosisD005355——15551325
ConstipationD003248—K59.01376925
Irritable bowel syndromeD043183EFO_0000555K58—1—21013
Acute-on-chronic liver failureD065290——2111510
End stage liver diseaseD058625EFO_1001311K72.1—22159
Liver failureD017093—K72.9—11248
Hepatic insufficiencyD048550———11338
Show 23 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ColonoscopyD003113———11—35
Abdominal painD015746EFO_0003766R10.9——1—34
Critical illnessD016638————2—13
AscitesD001201—R18——1—12
Digestive system diseasesD004066EFO_0000405K92.9—11—12
CandidiasisD002177—B37—12——2
Vulvovaginal candidiasisD002181EFO_0007543B37.3—12——2
DeliriumD003693—R41.0——1——1
Systemic sclerodermaD012595EFO_0000717M34——1——1
Lung diseasesD008171EFO_0003818J98.4——1——1
Show 13 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
InflammationD007249MP_0001845——1——23
InfectionsD007239EFO_0000544——1——12
Covid-19D000086382—U07.1—2———2
HypertensionD006973EFO_0000537I10—1———1
Multiple myelomaD009101—C90.0—1———1
Plasma cell neoplasmsD054219———1———1
Non-hodgkin lymphomaD008228—C85.9—1———1
LymphomaD008223—C85.9—1———1
Large b-cell lymphoma diffuseD016403—C83.3—1———1
B-cell lymphomaD016393———1———1
Show 9 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients———2———46
Insulin resistanceD007333EFO_0002614E88.8191———12
Crohn diseaseD003424EFO_0000384K501———12
Prediabetic stateD011236EFO_1001121R73.031————1
Opioid-related disordersD009293EFO_0005611F111————1
Gastric emptyingD005746——1————1
Postural orthostatic tachycardia syndromeD054972—G90.A1————1
Orthostatic intoleranceD054971——1————1
BurnsD002056—T30.01————1
Premature birthD047928EFO_0003917O601————1
Show 6 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Communicable diseasesD003141——————22
Blind loop syndromeD001765EFO_0007175K90.2————22
Inflammatory bowel diseasesD015212EFO_0003767—————22
Graft vs host diseaseD006086—D89.81————11
Colonic diseasesD003108——————11
Iron-deficiency anemiaD018798—D50————11
Iron deficienciesD000090463—E61.1————11
Metabolic diseasesD008659EFO_0000589E88.9————11
Growth disordersD006130——————11
Gastrointestinal motilityD005769——————11
Show 41 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
Kristalose – Cumberland Pharmaceuticals
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Estimated US medical usage
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
62 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use